News Focus
News Focus
icon url

misiu143

04/23/21 12:31 AM

#161008 RE: hotmeat #161006

You are right , they didn't run , but I think YOU not getting ,

They refused to permit 4 doses of leronlimab for
severe /critical , which is very logical base on a half life of the drug...

Dr Lalezari , Dr Yang , Dr Seethamraju asked for it ..

But they such an expert..They said not needed..

I wonder why FDA refused to approve study with 4 weeks of treatment ..hmmmm ..

All IMO.
icon url

bwolfy2002

04/23/21 12:53 AM

#161010 RE: hotmeat #161006

I had reached my limit of posts yesterday and have been waiting to cease this nonsense: the FDA approves trial design in so much as they say if you do it this way we will consider your results. Period. They did not approve 4 doses for CYDY’s trials and instead only approved 2 doses. No one but the FDA can permit a trial yielding data to be considered by them for approval in the US. So clearly they play a large role in all aspects of approval.